Crossmark

T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

Crossref DOI link: https://doi.org/10.1038/s41409-026-02951-9

Published Online: 2026-06-27

Published Print: 2026-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kayser, Sarah

Nagler, Arnon https://orcid.org/0000-0002-0763-1265
Ferhat, Allain Thibeault

Sanz, Jaime https://orcid.org/0000-0001-6934-4619
Devillier, Raynier https://orcid.org/0000-0002-4045-8310
Koc, Yener

Raiola, Anna Maria

Busca, Alessandro https://orcid.org/0000-0001-5361-5613
Kulagin, Alexander https://orcid.org/0000-0002-9589-4136
Vydra, Jan https://orcid.org/0000-0002-4274-3895
Itala-Remes, Maija

Bramanti, Stefania https://orcid.org/0000-0002-4117-7991
Grillo, Giovanni

Gulbas, Zafer

Pavlu, Jiri

Rovira, Montserrat

Sica, Simona https://orcid.org/0000-0003-2426-3465
Rambaldi, Alessandro https://orcid.org/0000-0002-3739-7502
Brissot, Eolia https://orcid.org/0000-0003-4471-418X
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
License Information

Text and Data Mining valid from 2026-06-27

Version of Record valid from 2026-06-27
More Information

Article History

Received: 31 March 2026

Revised: 27 May 2026

Accepted: 17 June 2026

First Online: 27 June 2026

Ethics

Competing interests: The authors declare no competing interests.

Ethics approval and consent to participate: The scientific boards of the ALWP of the EBMT approved this study. All methods were performed in accordance with the relevant guidelines and regulations.

Document is current

Any future updates will be listed below